pennvax-b
Vaccineexperimental
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00528489)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pennvax-b
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02431767 | Phase 1 | Aug 1, 2015 | Emory University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01082692 | Phase 1 | Jan 1, 2011 | Inovio Pharmaceuticals, University of Pennsylvania |
| NCT00775424 | Phase 1 | Sep 1, 2008 | Drexel University, University of Pennsylvania |
| NCT00528489 | Phase 1 | Oct 1, 2007 | HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), University of Washington |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 2007 |
| University of Pennsylvania | Academic/Hospital | 2 | 1 | 1 | 2008 |
| Drexel University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Emory University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| HIV Vaccine Trials Network | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Inovio Pharmaceuticals | For profit | 1 | 1 | 1 | 2011 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2007 |
7 organizations
Page 1 / 1